Delivery Order SPE2DB22D2005-SPE2DB24FJEU2

Award Date 11/20/23
Potential Completion Date 11/21/23
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of testosterone cypionate 200 mg/mL, a prescription medication, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., which is a major pharmaceutical distribution company. The contract has a ceiling value of $1,465.94 and a completion date of February 23, 2024. It is a firm-fixed-price delivery order contract with no set-aside designation, indicating open competition....
This federal contract award is for the delivery of testosterone cypionate 200 mg/mL pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The award, with a ceiling value of $1,103.74, was made to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 19, 2024. It is not associated with a set-aside designation. Amerisourcebergen holds...
This federal contract award is for the delivery of testosterone cypionate 200 mg/mL to the Defense Logistics Agency (DLA). The $1,860.86 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 4, 2024 with a completion date of December 5, 2024. The contract is not designated with any set-aside requirements. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $1,212.07, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of testosterone cypionate 200 mg/mL, a specialty medication. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for...
This federal contract award is for the delivery of testosterone cypionate, a pharmaceutical drug, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract has a ceiling value of $1,595.60 and is a firm fixed-price delivery order with a completion date of June 4, 2024. The contract is not designated as a set-aside procurement. Amerisourcebergen holds...
This federal contract award is for the delivery of TESTOSTERONE CYP 200 MG/MLML pharmaceuticals, with a ceiling value of $1,487.70. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award is for the delivery of 200 mg/mL testosterone cypionate to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $1,969.10, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. and a major pharmaceutical distributor. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical....
This federal contract award is for the delivery of Testosterone Cypionate 200 mg/mL, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,280 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 13, 2023, with a completion date of September 14, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,351.65 firm fixed-price delivery order is for the supply of testosterone cypionate 200 mg/mL, a specialty medication. The contract has an ultimate completion date of December 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,458.32 firm fixed-price delivery order contract is for the supply of testosterone cypionate 200 mg/mL, a specialty medication. The contract has an ultimate completion date of December 18, 2024 and was awarded on December 17, 2024. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB24FJEU2
    Delivery Order

This federal contract award is for the delivery of testosterone cypionate 200 mg/mL, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,017.55 and runs through November 2023. It is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and expiring in November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 5/12/25, 10:36 AM